Facebook
Twitter
LinkedIn
ForwardRecertification (MOC) Review Course (2016)
The purpose of the AUA Recertification (MOC) Review Course is to prepare attendees for the ABU Recertification Examination. This course will be practice focused and will offer practical and clinically-specific updates. It will highlight the AUA guidelines and address general urology practice issues that can be expected on the Recertification Exam. Sample multiple choice practice questions as well as case based discussions and debates will be utilized to prepare attendees for the upcoming Recertification Examination.
Target Audience
- Urologist
Learning Objectives
Upon completion of the course, participants will be able to:
- Review generally accepted urological practices for superior patient care
- Discuss a core knowledge of urology necessary for taking the Recertification Examination
- Examine the most recent changes and additions to the AUA guidelines
Friday, September 16, 2016
7:00 – 8:00 am Registration/Breakfast
8:00 – 8:10 am Introduction-Badrinath Konety, MD, MBA & Kevin McVary, MD, FACS
8:10 – 9:10 am Lower Urinary Tract Dysfunction/Neurogenic Bladder -Howard Goldman, MD, FACS
9:10 – 10:30 am Erectile Dysfunction/Infertility/ Hormone Replacement- Robert Brannigan, MD
10:30 – 10:45 am Break
10:45 – 11:30 am Prostate Cancer: Management of Localized and Systemic Disease-Peter Carroll, MD, MPH
11:30 am – 12:30 pm Renal Tumors- Mohamed Allaf, MD
12:30 – 1:30 pm Lunch
1:30 – 2:40 pm Female Urology- Howard Goldman, MD, FACS
2:40 – 3:45 pm Prostate Cancer: Diagnosis and Staging- Peter Carroll, MD, MPH
3:45 – 4:00 pm Break
4:00 – 5:00 pm General Pediatric Urology -Aseem Shukla, MD
5:00 – 5:30 pm Adrenal Disorders- Mohamed Allaf, MD
5:30 – 5:45 pm Mock Multiple Choice Exam and Review -Badrinath Konety, MD, MBA
5:45 pm Adjourn
5:45 – 6:30 pm Networking Reception
Saturday, September 17, 2016
7:00 – 7:30 am Breakfast
7:30 – 8:00 am Exam Overview and Test Taking Logistics -Gerald Jordan, MD
8:00 – 9:00 am Urothelial Bladder Cancer -Siamak Daneshmand, MD
9:00 – 10:00 am Benign Prostatic Hyperplasia -Kevin McVary, MD, FACS
10:00 – 10:15 am Break
10:15 – 11:00 am Testicular Cancer -Badrinath Konety, MD, MBA
11:00 am – 12:00 pm Upper Tract Tumors/Urinary Diversion-Siamak Daneshmand, MD
12:00 – 12:45 pm Lunch
12:45 – 1:45 pm Infections -Mantu Gupta, MD
1:45 – 2:45 pm Complications of Urologic Surgery-Kevin McVary, MD, FACS
2:45 – 3:45 pm Stone Disease/Benign Upper Tract Conditions -Mantu Gupta, MD
3:45 – 4:00 pm Break
4:00 – 4:45 pm Penile/Urethral Cancer-Badrinath Konety, MD, MBA
4:45 – 5:45 pm Trauma-Kurt McCammon, MD
5:45 – 6:00 pm Mock Multiple Choice Exam and Review-Kevin McVary, MD, FACS
6:00 pm Adjourn
To hold a reservation, a major credit card number must be provided.
$169 single/double occupancy. Make your reservation online using the Group Code: ARCARCA or call 1-800-241-3333. Reference the AUA Recertification (MOC) - Review Course 2016 when making your reservation over the phone to receive the special group rate.
Cut-off Date: Monday, August 15, 2016.
Once the AUA group block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or at this hotel.
Check-in: 3 p.m.
Check-out: Noon
| Name | Faculty Role | Company | COI Role | Financial | Date Disclosed |
|---|---|---|---|---|---|
| Kevin T. McVary, MD | Co-Director | AMS/Boston Scientific NeoTract Astellas Sophiris Merck | Consultant or Advisor,Meeting Participant or Lecturer,Scientific Study or Trial Consultant or Advisor,Meeting Participant or Lecturer,Scientific Study or Trial Scientific Study or Trial Scientific Study or Trial Consultant or Advisor | Yes Yes Yes Yes Yes | 04/11/2017 04/11/2017 06/19/2017 06/19/2017 06/19/2017 |
| Peter R. Carroll, MD, MPH | Co-Director | Nothing to Disclose | |||
| Howard B. Goldman, MD | Co-Director | Axonics NewUro Galvani | Consultant or Advisor Consultant or Advisor Consultant or Advisor | Yes Yes Yes | 04/04/2017 10/31/2017 01/15/2018 |
| Badrinath R. Konety, MD | Co-Director | Photocure Inc Genomic Health MDX Health Genentech/Roche FKD Therapeutics | Scientific Study or Trial Scientific Study or Trial Consultant or Advisor Scientific Study or Trial Scientific Study or Trial | No No Yes No Yes | 07/15/2017 07/15/2017 07/15/2017 07/15/2017 10/23/2017 |
| Mohamad E. Allaf, MD | Co-Director | Nothing to Disclose | |||
| Peter R. Carroll, MD, MPH | Faculty | Nothing to Disclose | |||
| Robert E. Brannigan, MD | Faculty | The American Society for Reproductive Medicine (ASRM) The American Society for Reproductive Medicine | Leadership Position,Health Publishing Leadership Position | No Yes | 09/29/2017 09/29/2017 |
| Howard B. Goldman, MD | Faculty | Axonics NewUro Galvani | Consultant or Advisor Consultant or Advisor Consultant or Advisor | Yes Yes Yes | 04/04/2017 10/31/2017 01/15/2018 |
| Mohamad E. Allaf, MD | Faculty | Nothing to Disclose | |||
| Aseem R. Shukla, MD | Faculty | Nothing to Disclose |
| Kevin T. McVary, MD | Co-Director | AMS/Boston Scientific NeoTract Astellas Sophiris Merck | Consultant or Advisor,Meeting Participant or Lecturer,Scientific Study or Trial Consultant or Advisor,Meeting Participant or Lecturer,Scientific Study or Trial Scientific Study or Trial Scientific Study or Trial Consultant or Advisor | Yes Yes Yes Yes Yes | 04/11/2017 04/11/2017 06/19/2017 06/19/2017 06/19/2017 |
| Mantu Gupta, MD | Co-Director | Cook Urological Olympus | Meeting Participant or Lecturer Consultant or Advisor,Meeting Participant or Lecturer,Scientific Study or Trial | Yes Yes | 02/23/2018 03/19/2018 |
| Badrinath R. Konety, MD | Co-Director | Photocure Inc Genomic Health MDX Health Genentech/Roche FKD Therapeutics | Scientific Study or Trial Scientific Study or Trial Consultant or Advisor Scientific Study or Trial Scientific Study or Trial | No No Yes No Yes | 07/15/2017 07/15/2017 07/15/2017 07/15/2017 10/23/2017 |
| Siamak Daneshmand, MD | Co-Director | Pacific Edge | Consultant or Advisor | Yes | 05/08/2017 |
| Mantu Gupta, MD | Faculty | Cook Urological Olympus | Meeting Participant or Lecturer Consultant or Advisor,Meeting Participant or Lecturer,Scientific Study or Trial | Yes Yes | 02/23/2018 03/19/2018 |
| Kurt A. McCammon, MD | Faculty | Boston Scientific Taris | Consultant or Advisor,Meeting Participant or Lecturer Scientific Study or Trial | Yes Yes | 03/05/2018 03/05/2018 |
| Siamak Daneshmand, MD | Faculty | Pacific Edge | Consultant or Advisor | Yes | 05/08/2017 |
| Gerald H. Jordan, MD, FACS | Speaker | Nothing to Disclose |
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Available Credit
- 17.25 AMA PRA Category 1 Credit™
- 17.25 Non-Physician Participation